Sclerostin | Zendy

Tilman B. Drüeke | Zendy; MarieHélène LafageProust | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Sclerostin

Author(s) -

Tilman B. Drüeke,

MarieHélène LafageProust

Publication year - 2011

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.01370211

Subject(s) - medicine , osteomalacia , renal osteodystrophy , sclerostin , osteopathy , chronic kidney disease mineral and bone disorder , osteitis , kidney disease , bone disease , osteoporosis , pathology , osteomyelitis , surgery , alternative medicine , gene , wnt signaling pathway , biochemistry , chemistry

Renal osteodystrophy (ROD) is one of the three components of chronic kidney disease–mineral and bone disorder (CKD-MBD) ([1][1]). Patients with CKD may develop various types of bone disease, spanning the spectrum of extreme situations such as severe osteitis fibrosa, osteomalacia, mixed osteopathy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research